tiprankstipranks
Advertisement
Advertisement

JSPR Stock Latest News

Jasper Therapeutics Receives Nasdaq Minimum Bid Price Notice
Company AnnouncementsJasper Therapeutics Receives Nasdaq Minimum Bid Price Notice
1M ago
8K
JSPR
Jasper Therapeutics Launches Strategic Alternatives Review Amid Uncertainty
PremiumCompany Announcements
Jasper Therapeutics Launches Strategic Alternatives Review Amid Uncertainty
1M ago
8K
JSPR
Jasper Therapeutics initiates review of strategic alternatives
PremiumThe Fly
Jasper Therapeutics initiates review of strategic alternatives
1M ago
JSPR
Jasper Therapeutics Announces Board Resignation and Committee Change
PremiumCompany Announcements
Jasper Therapeutics Announces Board Resignation and Committee Change
2M ago
8K
JSPR
Cisco, Arista, Jasper, StoneCo, Lisata Trending With Analysts
PremiumWeekend Updates
Cisco, Arista, Jasper, StoneCo, Lisata Trending With Analysts
2M ago
ANET
CSCO
Jasper Therapeutics price target lowered to $3 from $4 at RBC Capital
PremiumThe FlyJasper Therapeutics price target lowered to $3 from $4 at RBC Capital
2M ago
JSPR
Jasper Therapeutics downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Jasper Therapeutics downgraded to Hold from Buy at TD Cowen
2M ago
JSPR
Jasper Therapeutics price target lowered to $7 from $12 at Evercore ISI
Premium
The Fly
Jasper Therapeutics price target lowered to $7 from $12 at Evercore ISI
3M ago
JSPR
Jasper Therapeutics’ Deep Cuts May Backfire: Analyst Warns Downsizing Could Undermine Briquilimab Strategy and Cash Runway
PremiumCompany Announcements
Jasper Therapeutics’ Deep Cuts May Backfire: Analyst Warns Downsizing Could Undermine Briquilimab Strategy and Cash Runway
3M ago
JSPR
Buy Rating on Jasper: Briquilimab’s Strong CSU Efficacy, Favorable Safety, and Competitive Profile Underpin Key Near‑Term Value Driver
PremiumRatings
Buy Rating on Jasper: Briquilimab’s Strong CSU Efficacy, Favorable Safety, and Competitive Profile Underpin Key Near‑Term Value Driver
3M ago
JSPR
Jasper Therapeutics reports Q4 EPS (32c), consensus (82c)
PremiumThe Fly
Jasper Therapeutics reports Q4 EPS (32c), consensus (82c)
4M ago
JSPR
Jasper Therapeutics assumed with a Neutral at UBS
PremiumThe Fly
Jasper Therapeutics assumed with a Neutral at UBS
4M ago
JSPR
Jasper Therapeutics, Inc. (JSPR) Q4 Earnings Cheat Sheet
PremiumPre-EarningsJasper Therapeutics, Inc. (JSPR) Q4 Earnings Cheat Sheet
4M ago
JSPR
Jasper Therapeutics initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Jasper Therapeutics initiated with a Buy at Rodman & Renshaw
6M ago
JSPR
Briquilimab’s Robust Efficacy and Favorable Safety in Urticaria Indicate Strong Upside for Jasper Therapeutics and Support a Buy Rating
Premium
Ratings
Briquilimab’s Robust Efficacy and Favorable Safety in Urticaria Indicate Strong Upside for Jasper Therapeutics and Support a Buy Rating
6M ago
JSPR
Jasper Therapeutics Reports Strong Briquilimab Data in Urticaria
PremiumCompany Announcements
Jasper Therapeutics Reports Strong Briquilimab Data in Urticaria
6M ago
8K
JSPR
Jasper Therapeutics reports updated data from briquilimab studies
PremiumThe Fly
Jasper Therapeutics reports updated data from briquilimab studies
6M ago
JSPR
Maintaining Hold on Jasper: Awaiting Critical BEACON CSU Data to Resolve Clinical and Execution Uncertainty
PremiumRatings
Maintaining Hold on Jasper: Awaiting Critical BEACON CSU Data to Resolve Clinical and Execution Uncertainty
6M ago
JSPR
Jasper Therapeutics announces leadership transition and briquilimab update
PremiumCompany Announcements
Jasper Therapeutics announces leadership transition and briquilimab update
6M ago
8K
JSPR
Jasper Therapeutics says Jeet Mahal to succeed Ronald Martell as CEO
PremiumThe FlyJasper Therapeutics says Jeet Mahal to succeed Ronald Martell as CEO
6M ago
JSPR
3 Penny Stocks to Watch Now, 12/4/25
Premium
Market News
3 Penny Stocks to Watch Now, 12/4/25
7M ago
BQ
FTEL
Positive Outlook for Jasper Therapeutics: Buy Rating Reinforced by Briquilimab’s Promising Data and Strategic Plans
Premium
Ratings
Positive Outlook for Jasper Therapeutics: Buy Rating Reinforced by Briquilimab’s Promising Data and Strategic Plans
7M ago
JSPR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >